Mushroom and dietary selenium intakes in relation to fasting glucose levels in a free-living Italian adult population: The Moli-sani Project

Diabetes and Metabolism

Volumn 40, Issue 1, 2014, Pages 34-42

  Pounis, G ^a   Costanzo, S ^b   Persichillo, M ^b   de Curtis, A ^b   Sieri, S ^c   Vinceti, M ^d   Zito, F ^a   Di Castelnuovo, A F ^b   Donati, M B ^b   de Gaetano, G ^b   Iacoviello, L ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS NEUROMED   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Diabetes; Dietary habits; Glucose; Mushroom; Selenium

Indexed keywords

GLUCOSE; SELENIUM;

ADULT; ARTICLE; COMPARATIVE STUDY; DIABETES MELLITUS; DIET RESTRICTION; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GLUCOSE BLOOD LEVEL; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSHROOM; NUTRITIONAL ASSESSMENT; POPULATION; PREVALENCE;

DIABETES; DIETARY HABITS; GLUCOSE; MUSHROOM; SELENIUM;

AGARICALES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET SURVEYS; FASTING; FEMALE; FOOD HABITS; HUMANS; INDEPENDENT LIVING; ITALY; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SELENIUM; TRACE ELEMENTS;

EID: 84893714831     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.09.007     Document Type: Article

References (45)

1. Chang S.T. Mushrooms and mushroom cultivation 2001, eLS John Wiley & Sons Ltd, Chichester.
2. Mizuno T., Sakai T., Chihara G. Health foods and medicinal usages of mushrooms. Food Rev Int 1995, 11:69-81.
3. Ajith T.A., Janardhanan K.K. Indian medicinal mushrooms as a source of antioxidant and antitumor agents. J Clin Biochem Nutr 2007, 40:157-162.
4. Bobek P., Galbavy S. Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon. Br J Biomed Sci 2001, 58:164-168.
5. Cheung L.M., Cheung P.C.K. Mushroom extracts with antioxidant activity against lipid peroxidation. Food Chem 2005, 89:403-409.
6. Song Y.S., Kim S.H., Sa J.H., Jin C., Lim C.J., Park E.H. Antiangiogenic, antioxidant and xanthine oxidase inhibition activities of the mushroom Phellinus linteus. J Ethnopharmacol 2003, 88:113-116.
7. Matsuzawa T. Studies on antioxidant effects of culinary-medicinal bunashimeji mushroom Hypsizygus marmoreus (Peck) Bigel. (Agaricomycetideae). Int J Med Mushrooms 2006, 8:245-250.
8. Ikekawa T. Beneficial effects of edible and medicinal mushrooms on health care. Int J Med Mushrooms 2001, 3:291-298.
9. Chang J.H., Kim M.S., Kim J.Y., Choi W.H., Lee S.S. Effects of mushroom supplementation on blood glucose concentration, lipid profile, and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Korean J Nutr 2007, 40:327-333.
10. Sullivan R., Smith J.E., Rowan N.J. Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med 2006, 49:159-170.
11. Guillamón E., García-Lafuente A., Lozano M., D'Arrigo M., Rostagno M.A., Villares A., et al. Edible mushrooms: role in the prevention of cardiovascular diseases. Fitoterapia 2010, 81:715-723.
12. Jeong S.C., Jeong Y.T., Yang B.K., Islam R., Koyyalamudi S.R., Pang G., et al. White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutr Res 2010, 30:49-56.
13. United States Department of Agriculture (USDA) USDA reports by single nutrients 2013, Nutrient Data Laboratory, Barc-West Beltsville, US, MD 20705, [article online. Available from https://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/SR25/nutrlist/sr25w317.pdf. Accessed February 2013].
14. Pounis G., Costanzo S., di Giuseppe R., de Lucia F., Santimone I., Sciarretta A., et al. Consumption of healthy foods at different content of antioxidant vitamins and phytochemicals and metabolic risk factors for cardiovascular disease in men and women of the Moli-sani study. Eur J Clin Nutr 2013, 67:207-213.
15. Laclaustra M., Navas-Acien A., Stranges S., Ordovas J.M., Guallar E. Serum selenium concentrations and diabetes in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ Health Perspect 2009, 117:1409-1413.
16. Bleys J., Navas-Acien A., Guallar E. Serum selenium and diabetes in US adults. Diabetes Care 2007, 30:829-834.
17. Stranges S., Marshall J.R., Natarajan R., Donahue R.P., Trevisan M., Combs G.F., et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007, 147:217-223.
18. Bleys J., Navas-Acien A., Guallar E. Selenium and diabetes: more bad news for supplements. Ann Intern Med 2007, 147:271-272.
19. Mueller A.S., Mueller K., Wolf N.M., Pallauf J. Selenium and diabetes: an enigmaα. Free Radic Res 2009, 43:1029-1059.
20. Rocourt C.R.B., Cheng W.H. Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistanceα. Nutrients 2013, 5:1349-1365.
21. Steinbrenner H., Speckmann B., Pinto A., Sies H. High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J Clin Biochem Nutr 2011, 48:40-45. 10.3164/jcbn.11-002FR10.
22. Iacoviello L., Bonanni A., Costanzo S., De Curtis A., Di Castelnuovo A., Olivieri M., et al. The Moli-Sani Project, a randomized, prospective cohort study in the Molise region in Italy, design, rationale and objectives. Ital J Public Health 2007, 4:110-118.
23. Centritto F., Iacoviello L., di Giuseppe R., De Curtis A., Costanzo S., Zito F., et al. Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis 2009, 19:697-706.
24. Ada I. Classification and Diagnosis. Diabetes Care 2013, 36:S13.
25. Nuorti J.P., Butler J.C., Farley M.M., Harrison L.H., McGeer A., Kolczak M.S., et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000, 342:681-689.
26. Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32:498-504.
27. Pisani P., Faggiano F., Krogh V., Palli D., Vineis P., Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centers. Int J Epidemiol 1997, 26:152-160.
28. Pala V., Sieri S., Palli D., Salvini S., Berrino F., Bellegotti M., et al. Diet in the Italian EPIC cohorts: presentation of data and methodological issues. Tumori 2003, 89:594-607.
29. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione. Italian food composition tables 2013, Roma, Italy, Available from, Accessed 20 December 2011. http://www.inran.it/646/tabelle_di_composizione_degli_alimenti.html.
30. Food and Nutrition Board, Institute of Medicine Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. A report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes 2000, National Academy Press, Washington, DC.
31. Willett W.C., Howe G.R., Kushi L.H. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997, 65:1220S-1228S. [Discussion 1229S-1231S].
32. Hong S.A., Kim K., Nam S.J., Kong G., Kim M.K. A case-control study on the dietary intake of mushrooms and breast cancer risk among Korean women. Int J Cancer 2008, 122:919-923.
33. Lee S.A., Kang D., Nishio H., Lee M.J., Kim D.H., Han W., et al. Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med 2004, 36:116-121.
34. Zhang M., Huang J., Xie X., Holman C.D. Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer 2009, 124:1404-1408.
35. Ide T., Tsutsui H., Ohashi N., Hayashidani S., Suematsu N., Tsuchihashi M., et al. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 2002, 22:438-442.
36. Willett W.C., Stampfer M.J. Selenium and cancer. BMJ 1988, 297:573-574.
37. Rayman M.P. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 2005, 64:527-542.
38. Campos J.A., Tejera N.A., Sánchez C.J. Substrate role in the accumulation of heavy metals in sporocarps of wild fungi. Biometals 2009, 22:835-841.
39. Chang J.W., Chen H.L., Su H.J., Liao P.C., Guo H.R., Lee C.C. Simultaneous exposure of non-diabetics to high levels of dioxins and mercury increases their risk of insulin resistance. J Hazard Mater 2011, 185:749-755.
40. He K., Xun P., Liu K., Morris S., Reis J., Guallar E. Mercury exposure in young adulthood and incidence of diabetes later in life: the CARDIA Trace Element Study. Diabetes Care 2013, 36:1584-1589.
41. Edwards J.R., Prozialeck W.C. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 2009, 238:289-293.
42. Chen Y.W., Huang C.F., Yang C.Y., Yen C.C., Tsai K.S., Liu S.H. Inorganic mercury causes pancreatic beta-cell death via the oxidative stress-induced apoptotic and necrotic pathways. Toxicol Appl Pharmacol 2010, 243:323-331.
43. Chen Y.W., Huang C.F., Tsai K.S., Yang R.S., Yen C.C., Yang C.Y., et al. Methylmercury induces pancreatic beta-cell apoptosis and dysfunction. Chem Res Toxicol 2006, 19:1080-1085.
44. Chen Y.W., Huang C.F., Tsai K.S., Yang R.S., Yen C.C., Yang C.Y., et al. The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic beta-cell dysfunction in vitro and in vivo. Diabetes 2006, 55:1614-1624.
45. Dennert G., Zwahlen M., Brinkman M., Vinceti M., Zeegers M.P., Horneber M. Selenium for preventing cancer. Cochrane Database Syst Rev 2011, 5:CD005195.